The Biomarker Core will be primarily located in the Translational Research Laboratory (TRL), the same building which houses the Center for Sleep and Respiratory Neurobiology. The formation of the Biomarker Core will take advantage of existing facilities and the sophisticated equipment already available within the Translational Research Laboratory. The Biomarker Core will act as a central facility to collect, process and analyze the large number of incoming blood and urine samples generated by the clinical Projects 02 and 03 as well as rat tissue samples and isolated human monocytes derived from Projects 01 and 03. Importantly, the Biomarker Core will ensure quality control of all samples collected by the proposed projects. The objectives of the Biomarker Core are to: 1) standardize blood and urine collection between sites, 2) ensure proper handling and storage of samples, 3) code, record and monitor incoming samples 4) ensure quality control of assays and 5) provide a centralized facility for assays that are not available at other facilities within the institute. The Biomarker Core will be under the leadership of Dr. Karen Teff with Dr. Miroslaw Mackiewicz as Co-Core Leader and support staff consisting of a senior research technician and minimal effort from an additional technician in Dr. Teff's laboratory. Biomarkers will fall into the following categories: markers of oxidation and protective anti-oxidants, pro-inflammatory and anti-inflammatory markers, adhesion molecules, indices of insulin resistance and indices of sympathetic nervous system activity. The Biomarker Core will conduct three types of assays: 1) high-pressure liquid chromatography (HPLC) for measurement of plasma and urinary norepinephrine and metabolites such as normetanephrine as well as melatonin, a specific sleep-related biomarker, 2) spectrophotometric methods for the analysis of free fatty acids and triglycerides and 3) Reverse Transcription - Polymerase Chain Reaction (RT-PCR) on rat tongue tissue and isolated human monocytes. To avoid duplication of resources, we will take advantages of other cores at Penn. The Clinical and Translational Research Center Laboratory routinely conducts Enzyme Linked Immunosorbent Assay (ELISA) for the measurement of the inflammatory cytokines (IL-6, TNF-a), the anti-inflammatory cytokine (IL-10) and adhesion molecules (ICAM-1). In addition, markers of insulin resistance and sensitivity requiring radioimmunoassays (insulin, leptin, adiponectin) will be measured by the Penn Diabetes Research Center Radioimmunoassay Core. Urinary isoprostanes will be measured in the laboratory of Dr. Ian Blair, Professor of Chemistry and a renowned expert in markers of oxidative stress. Plasma glucose will be analyzed in the laboratory of Dr. Teff. A centralized facility will ensure quality control and cost effectiveness and will support future projects by establishing a bank of samples that will be available for future investigation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL094307-04
Application #
8377431
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
4
Fiscal Year
2012
Total Cost
$286,873
Indirect Cost
$92,345
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Feng, Yuan; Keenan, Brendan T; Wang, Stephen et al. (2018) Dynamic Upper Airway Imaging during Wakefulness in Obese Subjects with and without Sleep Apnea. Am J Respir Crit Care Med 198:1435-1443
Sands, Scott A; Edwards, Bradley A; Terrill, Philip I et al. (2018) Phenotyping Pharyngeal Pathophysiology using Polysomnography in Patients with Obstructive Sleep Apnea. Am J Respir Crit Care Med 197:1187-1197
Pien, Grace W; Ye, Lichuan; Keenan, Brendan T et al. (2018) Changing Faces of Obstructive Sleep Apnea: Treatment Effects by Cluster Designation in the Icelandic Sleep Apnea Cohort. Sleep 41:
Mazzotti, Diego R; Lim, Diane C; Sutherland, Kate et al. (2018) Opportunities for utilizing polysomnography signals to characterize obstructive sleep apnea subtypes and severity. Physiol Meas 39:09TR01
Sands, Scott A; Edwards, Bradley A; Terrill, Philip I et al. (2018) Identifying obstructive sleep apnoea patients responsive to supplemental oxygen therapy. Eur Respir J 52:
Keenan, Brendan T; Kim, Jinyoung; Singh, Bhajan et al. (2018) Recognizable clinical subtypes of obstructive sleep apnea across international sleep centers: a cluster analysis. Sleep 41:
van Hees, Vincent Theodoor; Sabia, S; Jones, S E et al. (2018) Estimating sleep parameters using an accelerometer without sleep diary. Sci Rep 8:12975
Shulman, Rachel; Cohen, Debbie L; Grandner, Michael A et al. (2018) Sleep duration and 24-hour ambulatory blood pressure in adults not on antihypertensive medications. J Clin Hypertens (Greenwich) 20:1712-1720
Gao, Xiaoling; Azarbarzin, Ali; Keenan, Brendan T et al. (2017) Heritability of Heart Rate Response to Arousals in Twins. Sleep 40:
Lyons, M Melanie; Keenan, Brendan T; Li, Junxin et al. (2017) Symptomless Multi-Variable Apnea Prediction Index Assesses Obstructive Sleep Apnea Risk and Adverse Outcomes in Elective Surgery. Sleep 40:

Showing the most recent 10 out of 51 publications